The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapy

The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapy

Yuan Wang,1 Guo-fang Hu,1 Zhe-hai Wang2 1School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, 2Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong, People’s Republic of China Background: Indoleamine 2,3-dioxygenase (IDO)...

Full description

Bibliographic Details
Main Authors: Wang Y, Hu GF, Wang ZH
Format: Article
Language:English
Published: Dove Medical Press 2017-07-01
Series:OncoTargets and Therapy
Subjects:
non-small cell lung cancer
Indoleamine 2
3-dioxygenase
immunosuppression
chemotherapy
Online Access:https://www.dovepress.com/the-status-of-immunosuppression-in-patients-with-stage-iiib-or-iv-non--peer-reviewed-article-OTT

Internet

https://www.dovepress.com/the-status-of-immunosuppression-in-patients-with-stage-iiib-or-iv-non--peer-reviewed-article-OTT

Similar Items